334 related articles for article (PubMed ID: 1971019)
21. Autoradiographic visualization of kappa opioid receptors with labelled dynorphins in guinea pig brain.
Slater P; Cross AJ; Hewitt L; Savage WJ
J Recept Res; 1989; 9(2):171-80. PubMed ID: 2568485
[TBL] [Abstract][Full Text] [Related]
22. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
Richards ML; Sadée W
J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
[TBL] [Abstract][Full Text] [Related]
23. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
[TBL] [Abstract][Full Text] [Related]
24. Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigms.
Weyhenmeyer JA; Mack KJ
Neuropharmacology; 1985 Feb; 24(2):111-5. PubMed ID: 2986030
[TBL] [Abstract][Full Text] [Related]
25. [3H]Mr 2034 labels a high affinity opioid kappa-receptor not accessible to naloxazone.
Ensinger HA
Eur J Pharmacol; 1983 Apr; 89(1-2):143-7. PubMed ID: 6305681
[TBL] [Abstract][Full Text] [Related]
26. Characterization of opioid binding sites in rat spinal cord.
Petrillo P; Kowalski J; Sbacchi M; Tavani A
J Recept Res; 1992; 12(1):39-57. PubMed ID: 1314311
[TBL] [Abstract][Full Text] [Related]
27. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Su TP
J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
[TBL] [Abstract][Full Text] [Related]
28. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
Clark JA; Liu L; Price M; Hersh B; Edelson M; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):461-8. PubMed ID: 2553920
[TBL] [Abstract][Full Text] [Related]
29. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor.
Xue JC; Chen C; Zhu J; Kunapuli S; DeRiel JK; Yu L; Liu-Chen LY
J Biol Chem; 1994 Dec; 269(48):30195-9. PubMed ID: 7982926
[TBL] [Abstract][Full Text] [Related]
30. Control of opiate receptor number in vivo: simultaneous kappa-receptor down-regulation and mu-receptor up-regulation following chronic agonist/antagonist treatment.
Morris BJ; Herz A
Neuroscience; 1989; 29(2):433-42. PubMed ID: 2542839
[TBL] [Abstract][Full Text] [Related]
31. Neuroanatomical localization of kappa 1 and kappa 2 opioid receptors in rat and guinea pig brain.
Unterwald EM; Knapp C; Zukin RS
Brain Res; 1991 Oct; 562(1):57-65. PubMed ID: 1666016
[TBL] [Abstract][Full Text] [Related]
32. A kinetic analysis of kappa-opioid agonist binding using the selective radioligand [3H]U69593.
Smith JA; Hunter JC; Hill RG; Hughes J
J Neurochem; 1989 Jul; 53(1):27-36. PubMed ID: 2723659
[TBL] [Abstract][Full Text] [Related]
33. Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for kappa opioid receptor subtypes.
Nock B; Rajpara A; O'Connor LH; Cicero TJ
Eur J Pharmacol; 1988 Sep; 154(1):27-34. PubMed ID: 2846324
[TBL] [Abstract][Full Text] [Related]
34. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
Horan P; de Costa BR; Rice KC; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
[TBL] [Abstract][Full Text] [Related]
35. Ligand binding profiles of U-69, 593-sensitive and-insensitive sites in human cerebral cortex membranes: evidence of kappa opioid receptors heterogeneity.
Kim KW; Eun YA; Soh SM; Eun JS; Cho KP
Life Sci; 1996; 58(19):1671-9. PubMed ID: 8632704
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
Das S; Bhargava HN
Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
[TBL] [Abstract][Full Text] [Related]
37. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
[TBL] [Abstract][Full Text] [Related]
38. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
Nock B; Rajpara A; O'Connor LH; Cicero TJ
Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
[TBL] [Abstract][Full Text] [Related]
39. A subset of kappa opioid ligands bind to the membrane glucocorticoid receptor in an amphibian brain.
Evans SJ; Searcy BT; Moore FL
Endocrinology; 2000 Jul; 141(7):2294-300. PubMed ID: 10875228
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
